AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glinist M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Venistro Biotech

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glinist M 2mg/500mg Tablet SR

Glinist M 2mg/500mg sustained-release tablets are classified as antidiabetic agents. This dual-medication formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-controlled blood sugar; abrupt cessation can lead to hyperglycemia and potentially serious complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are significantly impactful in diabetes control. Hypoglycemia (low blood sugar) is a prevalent adverse effect, characterized by symptoms like sweating, vertigo, cephalalgia, and tremor. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Consult your doctor before use during pregnancy or lactation. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to assess blood cell counts and liver function.

Uses of Glinist M 2mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glinist M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Glinist M 2mg/500mg Sustained-Release Tablets should be taken with a meal.

Common Side effects of Glinist M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glinist M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glinist M 2mg/500mg Extended-Release Tablets should be administered with a meal.

How Glinist M 2mg/500mg Tablet SR works:

Glinist M SR tablets (2mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glinist M 2mg/500mg Tablet SR and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glinist M 2mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glinist M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glinist M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glinist M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Glinist M 2mg/500mg Tablet SR should typically begin at a low dose; however, it's contraindicated in patients with severe liver disease.

What if you forget to take Glinist M 2mg/500mg Tablet SR :

Should you forget to take a Glinist M 2mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glinist M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glinist M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glinist M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Glinist M 2mg/500mg Tablet SR and seek immediate medical attention.
Glinist M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glinist M 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glinist M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glinist M 2mg/500mg SR tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glinist M 2mg/500mg SR tablets and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glinist M 2mg/500mg Table...
60
MRP 69
13% off